These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


435 related items for PubMed ID: 36252483

  • 21. Eupatilin inhibits pulmonary fibrosis by activating Sestrin2/PI3K/Akt/mTOR dependent autophagy pathway.
    Gong H, Lyu X, Liu Y, Peng N, Tan S, Dong L, Zhang X.
    Life Sci; 2023 Dec 01; 334():122218. PubMed ID: 37918625
    [Abstract] [Full Text] [Related]

  • 22. Design, synthesis and discovery of 2(1H)-quinolone derivatives for the treatment of pulmonary fibrosis through inhibition of TGF-β/smad dependent and independent pathway.
    Xue L, Deng D, Zheng S, Tang M, Yang Z, Pei H, Chen Y, Yang T, Liu K, Ye H, Chen L.
    Eur J Med Chem; 2020 Jul 01; 197():112259. PubMed ID: 32334267
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. SULF1 expression is increased and promotes fibrosis through the TGF-β1/SMAD pathway in idiopathic pulmonary fibrosis.
    Tu M, Lu C, Jia H, Chen S, Wang Y, Li J, Cheng J, Yang M, Zhang G.
    J Transl Med; 2024 Oct 01; 22(1):885. PubMed ID: 39354547
    [Abstract] [Full Text] [Related]

  • 28. Pazopanib attenuated bleomycin-induced pulmonary fibrosis via suppressing TGF-β1 signaling pathway.
    Huang K, Zhang Q, Ruan H, Guo C, Wu S, Liu Q, Zhang D, Long S, Wang W, Wu Z, Tian L, Gao S, Zhao H, Gu X, Yin H, Yang C.
    J Thorac Dis; 2024 Apr 30; 16(4):2244-2258. PubMed ID: 38738240
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A standardized herbal extract PM014 ameliorates pulmonary fibrosis by suppressing the TGF-β1 pathway.
    Kim KH, Lee S, Lee H, Shin D, Min D, Kim M, Ryu B, Kim HW, Bae H.
    Sci Rep; 2018 Nov 15; 8(1):16860. PubMed ID: 30443024
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Albendazole ameliorates aerobic glycolysis in myofibroblasts to reverse pulmonary fibrosis.
    Zeng C, Yue H, Wang C, Ju X, Wang T, Fu X, Zhou Q, Zhang H, He L, Yu J, Wang Y.
    J Transl Med; 2024 Oct 07; 22(1):910. PubMed ID: 39375691
    [Abstract] [Full Text] [Related]

  • 35. Niclosamide Ethanolamine Salt Alleviates Idiopathic Pulmonary Fibrosis by Modulating the PI3K-mTORC1 Pathway.
    Pei X, Zheng F, Li Y, Lin Z, Han X, Feng Y, Tian Z, Ren D, Cao K, Li C.
    Cells; 2022 Jan 20; 11(3):. PubMed ID: 35159160
    [Abstract] [Full Text] [Related]

  • 36. Pemafibrate attenuates pulmonary fibrosis by inhibiting myofibroblast differentiation.
    Liu Y, Chen S, Yu L, Deng Y, Li D, Yu X, Chen D, Lu Y, Liu S, Chen R.
    Int Immunopharmacol; 2022 Jul 20; 108():108728. PubMed ID: 35397395
    [Abstract] [Full Text] [Related]

  • 37. The small heat-shock protein αB-crystallin is essential for the nuclear localization of Smad4: impact on pulmonary fibrosis.
    Bellaye PS, Wettstein G, Burgy O, Besnard V, Joannes A, Colas J, Causse S, Marchal-Somme J, Fabre A, Crestani B, Kolb M, Gauldie J, Camus P, Garrido C, Bonniaud P.
    J Pathol; 2014 Mar 20; 232(4):458-72. PubMed ID: 24307592
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The mechanism of Shenlong Jianji treatment of idiopathic pulmonary fibrosis inhibits fibroblast-to-myofibroblast transformation via the TGF-β1/smads signaling pathway.
    Pan J, Li Y, Wu X, Pan X, Liu C, Zhang H, Wang L, Jiang X, Wang J, Zang N, Pang L, Lv X.
    J Ethnopharmacol; 2024 Mar 25; 322():117507. PubMed ID: 38122910
    [Abstract] [Full Text] [Related]

  • 40. Effective-compounds of Jinshui Huanxian formula ameliorates fibroblast activation in pulmonary fibrosis by inhibiting the activation of mTOR signaling.
    Li J, Li K, Tian Y, Zhao P, Liu X, Li M, Bai Y.
    Phytomedicine; 2023 Jan 25; 109():154604. PubMed ID: 36610143
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 22.